This program was made possible due to the support of the GEOQ and to unrestricted grants provided by the following pharmaceutical companies: AbbVie Corporation, Amgen Canada Inc., Astellas Pharma Canada, Astra Zeneca Canada, Beigene, Ltd., Boehringer Ingelheim Canada Ltd., Bristol-Myers Squibb Canada Co., Daiichi Sankyo Pharma Canada, Eisai Limited, Eli Lilly Canada Inc., Gilead Sciences Canada Inc., GlaxoSmithKline, Hoffman-La Roche Ltd., Incyte Biosciences Canada, Janssen Inc., Merck Canada Inc., Novartis Pharmaceuticals Canada Inc., Paladin Lab Inc., Pfizer Canada Inc., Sanofi Canada, Servier Canada Inc. and Takeda Canada Inc.